Table 5.
Net reclassification improvement based on addition of gene count score to Framingham offspring risk score
| Predicted diabetes risk (Framingham offspring risk score) | No of people | Reclassified | Net correctly reclassified (%) | |||||
|---|---|---|---|---|---|---|---|---|
| <5% | 5-10% | 10-15% | >15% | Increased risk | Decreased risk | |||
| Plus gene count score—people without diabetes during follow-up (n=3324) | ||||||||
| <5% | 2295 | 48 | 0 | 0 | 121 | 64 | −1.7 | |
| 5-9.9% | 36 | 482 | 43 | 0 | ||||
| 10-14.9% | 0 | 19 | 181 | 30 | ||||
| ≥15% | 0 | 0 | 9 | 181 | ||||
| Plus gene count score—people with diabetes during follow-up (n= 202) | ||||||||
| <5% | 52 | 8 | 0 | 0 | 14 | 11 | 1.5 | |
| 5-9.9% | 2 | 37 | 3 | 0 | ||||
| 10-14.9% | 0 | 4 | 24 | 3 | ||||
| ≥15% | 0 | 0 | 5 | 64 | ||||
Net reclassification improvement 0.2% (95% CI −5.1 to 4.7); P=0.94.